Entera Bio (ENTX) Leases (2019 - 2025)
Entera Bio has reported Leases over the past 7 years, most recently at $465000.0 for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 69.09% year-over-year to $465000.0, compared with a TTM value of $465000.0 through Dec 2025, up 69.09%, and an annual FY2025 reading of $465000.0, up 69.09% over the prior year.
- Leases came in at $465000.0 for Q4 2025, up from $194000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $465000.0 in Q4 2025 to a low of $48000.0 in Q1 2023.
- Median Leases over the past 5 years was $252500.0 (2021), compared with a mean of $267800.0.
- The sharpest move saw Leases plummeted 77.36% in 2023, then surged 693.75% in 2024.
- Over 5 years, Leases stood at $239000.0 in 2021, then plummeted by 62.34% to $90000.0 in 2022, then surged by 331.11% to $388000.0 in 2023, then dropped by 29.12% to $275000.0 in 2024, then skyrocketed by 69.09% to $465000.0 in 2025.
- Per Business Quant, the three most recent readings for ENTX's Leases are $465000.0 (Q4 2025), $194000.0 (Q3 2025), and $190000.0 (Q2 2025).